Amarin Corporation PLC (NASDAQ:AMRN)

2.94
Delayed Data
As of 4:00pm ET
 -0.05 / -1.67%
Today’s Change
2.82
Today|||52-Week Range
4.60
-26.68%
Year-to-Date
Moving Average Crossover Alert: Amarin (AMRN)
Apr 12 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close2.99
Today’s open3.00
Day’s range2.93 - 3.05
Volume3,679,278
Average volume (3 months)2,139,025
Market cap$1.1B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+37.94%
Earnings growth (this year)-18.82%
Earnings growth (next 5 years)-249.00%
Revenue growth (last year)+41.69%
P/E ratioNM
Price/Sales5.93
Price/Book--

Competitors

----
RGNXRegenxbio Inc+0.55+1.41%
MEDPMedpace Holdings Inc-0.26-0.70%
CLXTCalyxt Inc-0.04-0.24%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 11, 2018
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$183.0M
Annual profit (last year)-$68.6M
Net profit margin-37.47%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
SVP-
Manufacturing Operations
Derek Kalinowski
Corporate headquarters
Dublin, Dublin

Forecasts